Innovage Holding Corp. (INNV) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Innovage Holding Corp. (INNV) stock forecast summary
Our AI ranks Innovage Holding Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Innovage Holding Corp. is a small-cap company with a market capitalization of $1.23B. It ranks number 6 by market capitalization among the 10 Services-Health Services issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for INNV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.7% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, INNV included.
Follow INNV freeINNV price chart and AI forecast
How INNV ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Innovage Holding Corp. (INNV) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Health Services peers listed below that report each metric.
Valuation & Market
| Metric | INNV | Rank |
|---|---|---|
| Market Cap | $1.23B | 6/10 |
| P/B Ratio | 5.22x | 2/9 |
| EPS | $-0.02 | – |
| Book Value/Share | $1.73 | – |
| Revenue/Share | $7.25 | – |
| FCF/Share | $0.37 | – |
Profitability & Margins
| Metric | INNV | Rank |
|---|---|---|
| ROE | -1.1% | 5/10 |
| ROA | -0.5% | 5/10 |
| ROIC | 0.7% | 5/11 |
| Gross Margin | 23.0% | 5/8 |
| Operating Margin | 0.3% | 5/12 |
| Net Margin | -0.3% | 5/10 |
| EBT Margin | 0.0% | 5/12 |
| Tax Rate | 356.8% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | INNV | Rank |
|---|---|---|
| Current Ratio | 1.05x | 10/11 |
| D/E Ratio | 1.23x | 3/12 |
| Financial Leverage | 2.37x | 3/12 |
| Interest Coverage | 10.6x | 5/11 |
| Working Capital | $10M | 10/11 |
Cash Flow
| Metric | INNV | Rank |
|---|---|---|
| Operating Cash Flow | $65M | 4/13 |
| Free Cash Flow | $50M | 3/9 |
| Capital Spending | -$14M | 5/9 |
| OCF Growth YoY | 96.9% | 1/8 |
| FCF Growth YoY | 89.5% | 1/6 |
| FCF/Sales | 5.1% | 4/9 |
| CapEx/Sales | 1.4% | 6/9 |
Operational Efficiency
| Metric | INNV | Rank |
|---|---|---|
| Asset Turnover | 1.78x | 2/11 |
| Receivables Turnover | 23.4x | 1/9 |
| Fixed Assets Turnover | 6.5x | 9/10 |
| Days Sales Outstanding | 16 days | 9/9 |
Income Statement
| Metric | INNV | Rank |
|---|---|---|
| Total Revenue | $989M | 5/11 |
| Operating Income | $2M | 5/13 |
| Net Income | -$2M | 7/11 |
| SG&A Expense | $215M | 5/11 |
Dividend & Shareholder Information
| Metric | INNV | Rank |
|---|---|---|
| Shares Outstanding | 136M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $214M | 38.4% of assets |
| Cash & Short-term Investments | $98M | 17.6% of assets |
| Accounts Receivable | $42M | 7.6% of assets |
| Total Liabilities | $289M | 51.8% of assets |
INNV quarterly financials and insider trading
Innovage Holding Corp. (INNV) industry peers
Companies classified under the same SEC industry code as Innovage Holding Corp. (Services-Health Services): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| INNV Innovage Holding Corp. | ▲ | $1.23B |
| LFST Lifestance Health Group, Inc. | ▲ | $4.71B |
| PRVA Privia Health Group, Inc. | ▼ | $2.77B |
| WGS Genedx Holdings Corp. | ▲ | $1.94B |
| PNTG Pennant Group, Inc. | ▶ | $1.40B |
| USPH U S Physical Therapy Inc /Nv | ▶ | $1.27B |
| OMDA Omada Health, Inc. | ▲ | $1.12B |
| SRTA Strata Critical Medical, Inc. | ▲ | $394M |
| EUDA Euda Health Holdings Ltd | ▶ | $32M |
| DCGO Docgo Inc. | ▲ | $30M |
| ATPC Agape Atp Corp | ▼ | N/A |
| PIII P3 Health Partners Inc. | ▲ | N/A |
| VSEE Vsee Health, Inc. | ▼ | N/A |
Where INNV sits on the market map
Innovage Holding Corp. (INNV) stock news
Loading...
Innovage Holding Corp. (INNV) stock forecast FAQ
What is the Innovage Holding Corp. (INNV) stock forecast?
Our AI ranks Innovage Holding Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Innovage Holding Corp. stock predictions?
A per-ticker accuracy statistic for INNV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Innovage Holding Corp. forecasts updated?
Innovage Holding Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Innovage Holding Corp.'s industry peers?
13 issuers in our coverage, INNV included, share the SEC industry code Services-Health Services. The largest are: Lifestance Health Group, Inc. (LFST), Privia Health Group, Inc. (PRVA), Genedx Holdings Corp. (WGS), Pennant Group, Inc. (PNTG), U S Physical Therapy Inc /Nv (USPH), Omada Health, Inc. (OMDA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.